A concise up-to-date review of the many new therapies available for the treatment of benign
prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive
therapies as well as time-tested surgical treatments and review the medical therapies for BPH
namely a-adrenergic antagonists 5-a reductase inhibitors and their therapeutic combinations.
Additional chapters examine the pathophysiology and natural history of BPH its epidemiology
and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for
the practicing urologist seeking sound guidance on the best approach to his patients.
